Effects of 8-chloro-cyclic adenosine monophosphate on the growth and sensitivity to doxorubicin of multidrug-resistant tumour cell lines.

Abstract

We examined the in vitro effects of 8-chloro-adenosine 3':5'-monophosphate (8-Cl-cAMP), a reportedly stable, potent and site-selective analogue of cAMP, on the proliferation and sensitivity to doxorubicin (DXR) of two mouse cell lines, the B16 melanoma and Friend leukaemia, both as wild-type (B16, FLC) and DXR-resistant (B16/DXR, FLC/DXR) variants. The latter strains had characteristics of 'typical' multidrug resistance (MDR), including the over-expression of P-glycoprotein. Encouragingly, 8-Cl-cAMP affected almost equally the growth of the chemosensitive and chemoresistant variants of both cell lines. Its activity proved to be much more elevated on cells cultivated with fresh rather than heat-inactivated calf serum. In fact, the IC50 values for B16 and B16/DXR were about 4.7 microM in fresh serum and 215 microM in heat-inactivated serum; the IC50 values for FLC and FLC/DXR were about 12 microM in fresh serum and 70 microM in heat-inactivated serum. Furthermore, experiments with B16 showed that cotreatments with isobutylmethylxanthine (IBMX), a phosphodiesterase inhibitor, or adenosine deaminase (ADA) greatly reduce the activity of 8-Cl-cAMP bringing it to comparable levels in fresh and heat-inactivated serum. These results indicate that the antiproliferative effects of 8-Cl-cAMP may be due principally to metabolites formed by the enzymic activities of the serum, most probably including 8-chloro-adenosine (8-Cl-adenosine), as suggested by other authors. Moreover, the dose-response curves and the IC50 values of the latter compound for the various cell lines were compatible with those observed for 8-Cl-cAMP in fresh serum. Finally, there was no evidence that 8-Cl-cAMP, either in the presence of fresh or heat-inactivated serum, or 8-Cl-adenosine may increase the sensitivity to DXR of the MDR variants of B16 melanoma and Friend leukaemia.

• Authors: N Borsellino, M Crescimanno, V Leonardi, N D'Alessandro
• Journal: Pharmacological research (Pharmacol Res) Vol. 30 Issue 1 Pg. 81-90 (Jul 1994) ISSN: 1043-6618 [Print] Netherlands
• PMID: 7831198 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents
• 2-Chloroadenosine
• 8-Bromo Cyclic Adenosine Monophosphate
• Doxorubicin
• 8-chloro-cyclic adenosine monophosphate
• 8-chloroadenosine

Topics

• 2-Chloroadenosine (analogs & derivatives, pharmacology)
• 8-Bromo Cyclic Adenosine Monophosphate (analogs & derivatives, pharmacology)
• Animals
• Antineoplastic Agents (pharmacology)
• Cell Division (drug effects)
• Doxorubicin (pharmacology)
• Drug Resistance, Multiple
• Melanoma, Experimental (pathology)
• Mice
• Tumor Cells, Cultured